Arrhythmia Disorders News

A large analysis of UK Biobank data indicated no increased CV risk from birth control and even suggested a potential cardioprotective effect from oral contraceptive use, researchers reported.

Boston Scientific announced it received FDA approval for its cryoablation system indicated for the treatment of patients with paroxysmal atrial fibrillation.

Subcutaneous implantable cardioverter defibrillators are effective in preventing arrhythmic death in people with congenital heart disease, with the devices successfully terminating all life-threatening ventricular arrhythmias, data show.

Biosense Webster announced several of its products in its cardiac ablation portfolio have received FDA approval for use without fluoroscopy.

Implantable device data show patients with shock-resistant atrial fibrillation fare better than conventional analyses demonstrate, experiencing a marked reduction in atrial tachyarrhythmia burden despite modest arrhythmia-free survival.

Healio | Cardiology Today has compiled a list of the top headlines in cardiology of July 2023.

GE HealthCare announced a recall of arterial oxygen saturation sensors due to a malfunction that may reduce the amount of energy sent to the heart during defibrillation without notification to the care provider.

Abbott announced a recall of its cardiac catheter used in procedures for left atrial appendage occlusion due to risk for air embolism, potentially causing stroke or death.

Asian individuals experience poorer outcomes after out-of-hospital cardiac arrest in the U.S. compared with white individuals, despite similar rates of bystander CPR, researchers reported.

Biosense Webster announced the U.S. launch of a catheter to help electrophysiologists with mapping complex cardiac arrhythmias.